Your session is about to expire
← Back to Search
Quitbot Program for Smoking Cessation
Phase 3
Waitlist Available
Led By Jonathan B. Bricker
Research Sponsored by Fred Hutchinson Cancer Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 and 6 months after randomization
Awards & highlights
Study Summary
This trial is comparing two different ways to help people quit smoking cigarettes.
Who is the study for?
This trial is for smokers who have smoked at least one cigarette daily for the past year, want to quit within a month, and are willing to try a digital program. They must live in the US, read English, not use other cessation methods, be open to random assignment to either program, and have daily access to a smartphone with text messaging and Facebook Messenger.Check my eligibility
What is being tested?
The study compares two remote digital smoking cessation programs. Participants will receive support through their smartphones using either an experimental or control program designed to help them stop smoking.See study design
What are the potential side effects?
Since this trial involves non-medical interventions (digital programs), traditional side effects like those from drugs aren't expected. However, participants may experience stress or frustration related to quitting smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 3 and 6 months after randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 and 6 months after randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Number of participants with 30-day biochemically confirmed cigarette smoking cessation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (QuitBot Experimental)Experimental Treatment1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.
Group II: Group II (QuitBot Control)Active Control1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.
Find a Location
Who is running the clinical trial?
Fred Hutchinson Cancer Research CenterLead Sponsor
443 Previous Clinical Trials
146,725 Total Patients Enrolled
Fred Hutchinson Cancer CenterLead Sponsor
556 Previous Clinical Trials
1,341,748 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,932,147 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not meet the specific requirements listed for the trial.I am 18 years old or older.I want to quit smoking within the next 30 days.I use nicotine or tobacco products but want to quit within 30 days.You are not using any other methods to quit smoking during the study.
Research Study Groups:
This trial has the following groups:- Group 1: Group I (QuitBot Experimental)
- Group 2: Group II (QuitBot Control)
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people can join this study at most?
"That is correct. As of 8/12/2022, this clinical trial is still recruiting patients that meet the eligibility criteria. So far, 1520 people have been enrolled at a single site."
Answered by AI
What does the FDA think of the QuitBot Smoking Cessation Program?
"There is some evidence to support the efficacy of QuitBot Smoking cessation Program, as it is a Phase 3 trial. Furthermore, there is robust data supporting its safety, so it receives a score of 3."
Answered by AI
Can people with the specified medical condition participate in this trial right now?
"That is correct, the clinicaltrials.gov website has information showing that this study is still recruiting patients. The trial was posted on July 24th, 2020 and was last updated on August 12th, 2020. The study is looking for 1520 patients at 1 site."
Answered by AI
Who else is applying?
What state do they live in?
Wisconsin
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger